Evidence map›Paper›PMID 38921818›Full record

ArticlePathogens (Basel, Switzerland)2024

Epidemiological Characterization and Genetic Variation of the SARS-CoV-2 Delta Variant in Palestine.

Suheir Ereqat, Nabil-Fareed Alikhan, Amer Al-Jawabreh, Michaela Matthews, Ahmed Al-Jawabreh, Leonardo de Oliveira Martins, Alexander J Trotter, Mai Al-Kaila, Andrew J Page, Mark J Pallen and 1 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Suheir EreqatBiochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis, Jerusalem P.O. Box 51000, Palestine.
Nabil-Fareed AlikhanQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Amer Al-JawabrehDepartment of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Arab American University, Jenin P.O. Box 240, Palestine.ORCID 0000-0001-5929-8743
Michaela MatthewsQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.ORCID 0000-0002-9704-4864
Ahmed Al-JawabrehBiochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis, Jerusalem P.O. Box 51000, Palestine.
Leonardo de Oliveira MartinsQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.ORCID 0000-0001-5247-1320
Alexander J TrotterQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Mai Al-KailaMinistry of Health of the State of Palestine, Ramallah P6028100, Palestine.
Andrew J PageQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Mark J PallenQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Abedelmajeed NasereddinBiochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis, Jerusalem P.O. Box 51000, Palestine.

Funding

BBSRC, Institute Strategic Programme Microbes in the Food Chain BB/R012504/1, BBS/E/F/000PR10352, and BB/CCG1860/1
6 · The paper itself

Abstract

The emergence of new SARS-CoV-2 variants in Palestine highlights the need for continuous genetic surveillance and accurate screening strategies. This case series study aimed to investigate the geographic distribution and genetic variation of the SARS-CoV-2 Delta Variant in Palestine in August 2021. Samples were collected at random in August 2021 (

Indexed as

COVID-19Genetic VariationPhylogenySARS-CoV-2FemaleGenome, ViralHaplotypesHumansMaleMiddle EastCOVID-19genomic epidemiologymutationPalestineSARS-CoV-2

Identifiers

PMID38921818
PMCPMC11206313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.